Estrella Immunopharma - 53 Year Dividend History | ESLA
Historical dividend payout and yield for Estrella Immunopharma (ESLA) since 1971. The current TTM dividend payout for Estrella Immunopharma (ESLA) as of December 20, 2024 is $0.00. The current dividend yield for Estrella Immunopharma as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.042B |
$0.000B |
|
Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS(R) T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. The company's lead product candidate includes EB103 and EB104. Estrella Immunopharma Inc., formerly known as TradeUP Acquisition Corp., is based in NEW YORK.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
